On the other hand, the gut microbiota has been associated with the development of obesity, metabolic syndrome, and type 2 diabetes due to its impact on reduced glucose tolerance and insulin sensitivity, and gut microbiota dysbiosis is associated with inflammation and the progression of diabetic complications in people with type 2 diabetes [62,63]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.